β-glucans and cholesterol (Review)

Hypercholesterolemia is one of primary risk factors of cardiovascular disease, together with metabolic syndrome, hypertension and diabetes. Although progress has been made, the search for novel methods of preventing and treating dyslipidemia is ongoing and current therapies for cardiovascular disease induce various side effects. β-glucans are linear unbranched polysaccharides found in various natural sources, such as mushrooms. Due to their structure they are able to interact with innate immunity receptors, however they also act as dietary fibers in the digestive tract. As there are two forms of β-glucans, insoluble and soluble forms, they are able to interact with lipids and biliary salts in the bowel and consequently reduce cholesterol levels. Therefore, they may be developed as a suitable therapeutic option to treat patients with dyslipidemia, as they are natural molecules that do not induce any significant side effects. The current review discusses the evidence supporting the effects of β-glucans on cholesterol levels.

[1]  N. A. Pikaar,et al.  Cholesterol-lowering effect of rolled oats. , 1963, Lancet.

[2]  R. E. Miller,et al.  Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. , 1981, The American journal of clinical nutrition.

[3]  I. Johnson,et al.  Effect of gel-forming gums on the intestinal unstirred layer and sugar transport in vitro. , 1981, Gut.

[4]  N. A. Blackburn,et al.  The influence of guar gum on intestinal cholesterol transport in the rat , 1983, British Journal of Nutrition.

[5]  J. Anderson,et al.  Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. , 1984, The American journal of clinical nutrition.

[6]  M. Brown,et al.  How LDL receptors influence cholesterol and atherosclerosis. , 1984, Scientific American.

[7]  P. Torrence.  Biological response modifiers : new approaches to disease intervention , 1985 .

[8]  J. Czop.  The role of beta-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation. , 1986, Pathology and immunopathology research.

[9]  J. Fadel,et al.  Hypocholesterolemic effects of beta-glucans in different barley diets fed to broiler chicks , 1987 .

[10]  J. Anderson,et al.  Hypocholesterolemic effects of oat and bean products. , 1988, The American journal of clinical nutrition.

[11]  D. Williams,et al.  Effect of enhanced macrophage function on early wound healing. , 1988, Surgery.

[12]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[13]  R. K. Newman,et al.  Hypocholesterolemic effect of barley foods on healthy men , 1989 .

[14]  N. Simionescu,et al.  Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster. , 1990, Journal of submicroscopic cytology and pathology.

[15]  H. C. Stary,et al.  The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. , 1990, European heart journal.

[16]  P. Nestel,et al.  Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men. , 1991, The American journal of clinical nutrition.

[17]  V. Vetvicka,et al.  CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions , 1993, Clinical and experimental immunology.

[18]  J. Cerda,et al.  The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. , 1993, Laboratory animal science.

[19]  J. Lupton,et al.  Cholesterol-lowering effect of barley bran flour and oil. , 1994, Journal of the American Dietetic Association.

[20]  P. Wood,et al.  Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. , 1994, European journal of clinical nutrition.

[21]  G. Hallmans,et al.  Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. , 1995, The American journal of clinical nutrition.

[22]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[23]  C. Yun,et al.  Immunomodulatory activities of oat beta-glucan in vitro and in vivo. , 1997, Microbiology and immunology.

[24]  F. Pi‐Sunyer,et al.  The Role of Viscous Soluble Fiber in the Metabolic Control of Diabetes: A review with special emphasis on cereals rich in β-glucan , 1997, Diabetes Care.

[25]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[26]  B. Rosner,et al.  Cholesterol-lowering effects of dietary fiber: a meta-analysis. , 1999, The American journal of clinical nutrition.

[27]  T. Mayadas,et al.  The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. , 1999, Journal of immunology.

[28]  B. Bistrian,et al.  Effect of beta-glucan from oats and yeast on serum lipids. , 1999, Critical reviews in food science and nutrition.

[29]  C. Kendall,et al.  Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. , 2000, Current opinion in lipidology.

[30]  F. Brancati,et al.  The challenge of obesity-related chronic diseases , 2000, Journal of general internal medicine.

[31]  Inhibition of LPS-induced NFkappaB activation by a glucan ligand involves down-regulation of IKKbeta kinase activity and altered phosphorylation and degradation of IkappaBalpha. , 2000, Shock.

[32]  The hyperlipemic hamster ‐ a model for testing the anti‐atherogenic effect of amlodipine , 2001, Journal of cellular and molecular medicine.

[33]  S. Young,et al.  Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[34]  S. Srinivasan,et al.  Distribution and correlates of non-high-density lipoprotein cholesterol in children: the Bogalusa Heart Study. , 2002, Pediatrics.

[35]  W. Davidson,et al.  The Spatial Organization of Apolipoprotein A-I on the Edge of Discoidal High Density Lipoprotein Particles , 2003, Journal of Biological Chemistry.

[36]  Y. Wang,et al.  Effects of barley intake on glucose tolerance, lipid metabolism, and bowel function in women. , 2003, Nutrition.

[37]  A. Sato,et al.  Long-term effects of high dietary fiber intake on glucose tolerance and lipid metabolism in GK rats: comparison among barley, rice, and cornstarch. , 2003, Metabolism: clinical and experimental.

[38]  Maureen E. Taylor,et al.  Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells. , 2003, Glycobiology.

[39]  S. Frazer,et al.  Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. , 2003, The Journal of nutrition.

[40]  G. Cooper,et al.  Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. , 2003, The American journal of clinical nutrition.

[41]  Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme , 2003, The Lancet.

[42]  D. Russell.  The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[43]  K. M. Behall,et al.  Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. , 2004, The American journal of clinical nutrition.

[44]  R. Nicolosi,et al.  Reduced and high molecular weight barley beta-glucans decrease plasma total and non-HDL-cholesterol in hypercholesterolemic Syrian golden hamsters. , 2004, The Journal of nutrition.

[45]  K. M. Behall,et al.  Lipids Significantly Reduced by Diets Containing Barley in Moderately Hypercholesterolemic Men , 2004, Journal of the American College of Nutrition.

[46]  B. Kemp,et al.  High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Gibbons,et al.  Synthesis and function of hepatic very-low-density lipoprotein. , 2004, Biochemical Society transactions.

[48]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[49]  C. Chau,et al.  Effects of the insoluble fiber derived from Passiflora edulis seed on plasma and hepatic lipids and fecal output. , 2005, Molecular nutrition & food research.

[50]  S. Gordon,et al.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.

[51]  Joanne L Slavin,et al.  Dietary fiber and body weight. , 2005, Nutrition.

[52]  R. Mensink,et al.  Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with β-glucans from oats or barley: a randomised dose-controlled trial , 2005, European Journal of Clinical Nutrition.

[53]  D. Gordon,et al.  High-Density Lipoprotein Cholesterol and Cardiovascular Disease , 2005 .

[54]  E. Levy,et al.  Short-chain fatty acids: ready for prime time? , 2006, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[55]  L. Serra-Majem,et al.  Scientific evidence of interventions using the Mediterranean diet: a systematic review. , 2006, Nutrition reviews.

[56]  T. Shamliyan,et al.  The effects of concentrated barley β-glucan on blood lipids in a population of hypercholesterolaemic men and women , 2007, British Journal of Nutrition.

[57]  Dennis D Black,et al.  Development and physiological regulation of intestinal lipid absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[58]  R. Simon,et al.  Toxicological assessment of a particulate yeast (1,3/1,6)-beta-D-glucan in rats. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[59]  T. Ha,et al.  Hypolipidemic effect of soluble fiber isolated from seeds of Cassia tora Linn. in rats fed a high-cholesterol diet. , 2007, Journal of agricultural and food chemistry.

[60]  Charles M Mansbach,et al.  Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[61]  V. Vetvicka,et al.  Physiological effects of different types of beta-glucan. , 2007, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[62]  V. Vetvicka,et al.  β-Glucans, History, and the Present: Immunomodulatory Aspects and Mechanisms of Action , 2008, Journal of immunotoxicology.

[63]  Zhenghong Xu,et al.  Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. , 2008, Journal of ethnopharmacology.

[64]  K. Mori,et al.  Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake), and Hypsizygus marmoreus (Bunashimeji) in apolipoprotein E-deficient mice. , 2008, Nutrition research.

[65]  R. Newman,et al.  Barley for food and health : science, technology, and products , 2008 .

[66]  Catherine M Champagne,et al.  The evidence for dietary prevention and treatment of cardiovascular disease. , 2008, Journal of the American Dietetic Association.

[67]  Effect of high beta-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men--a randomized, double-blinded, placebo-controlled trial. , 2008, Plant foods for human nutrition.

[68]  Raj Padwal,et al.  Body mass index and mortality in heart failure: a meta-analysis. , 2008, American heart journal.

[69]  M. R. Hoenig,et al.  Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target , 2008, Vascular health and risk management.

[70]  Pat Baird,et al.  Health benefits of dietary fiber. , 2009, Nutrition reviews.

[71]  J. Chiang,et al.  Regulation of Bile Acid and Cholesterol Metabolism by PPARs , 2009, PPAR research.

[72]  B. Kemp,et al.  AMPK in Health and Disease. , 2009, Physiological reviews.

[73]  Avani A. Pendse,et al.  Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond This work was supported by National Institutes of Health Grant HL-042630. Published, JLR Papers in Press, December 5, 2008. , 2009, Journal of Lipid Research.

[74]  C. White,et al.  The Effects of Barley-Derived Soluble Fiber on Serum Lipids , 2009, The Annals of Family Medicine.

[75]  V. Vetvicka,et al.  Effects of yeast-derived β-glucans on blood cholesterol and macrophage functionality , 2009, Journal of immunotoxicology.

[76]  S. Gómez-Martínez,et al.  Nutrition, Inflammation, and Cognitive Function , 2009, Annals of the New York Academy of Sciences.

[77]  Xu-Feng Huang,et al.  The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. , 2009, Journal of clinical lipidology.

[78]  A. Tall,et al.  Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[79]  F. McAlister,et al.  Association between direct measures of body composition and prognostic factors in chronic heart failure. , 2010, Mayo Clinic proceedings.

[80]  S. Parthasarathy,et al.  Oxidized low-density lipoprotein. , 2010, Methods in molecular biology.

[81]  N. Ames,et al.  β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials , 2010, European Journal of Clinical Nutrition.

[82]  T. Wolever,et al.  Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. , 2010, The American journal of clinical nutrition.

[83]  F. Temelli,et al.  Beta-glucan extracts inhibit the in vitro intestinal uptake of long-chain fatty acids and cholesterol and down-regulate genes involved in lipogenesis and lipid transport in rats. , 2010, The Journal of nutritional biochemistry.

[84]  S. Brix,et al.  Dietary fibers as immunoregulatory compounds in health and disease , 2010, Annals of the New York Academy of Sciences.

[85]  V. Vetvicka,et al.  1,3-Glucan: Silver Bullet or Hot Air? , 2010 .

[86]  R. Sato.  Sterol metabolism and SREBP activation. , 2010, Archives of biochemistry and biophysics.

[87]  M. Peppelenbosch,et al.  Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. , 2010, Biochimica et biophysica acta.

[88]  L. Barsanti,et al.  Chemistry, physico-chemistry and applications linked to biological activities of β-glucans. , 2011, Natural product reports.

[89]  K. Engel,et al.  In vitro model to correlate viscosity and bile acid-binding capacity of digested water-soluble and insoluble dietary fibres , 2011 .

[90]  M. Rondanelli,et al.  Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men , 2011, European Journal of Clinical Nutrition.

[91]  G. Phillips,et al.  An introduction: Evolution and finalisation of the regulatory definition of dietary fibre , 2011 .

[92]  Faloia Emanuela,et al.  Inflammation as a Link between Obesity and Metabolic Syndrome , 2012, Journal of nutrition and metabolism.

[93]  Michael J. Miller,et al.  The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. , 2012, Metabolism: clinical and experimental.

[94]  T. Lüscher,et al.  Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease , 2012, EMBO molecular medicine.

[95]  S. Haffner,et al.  Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. , 2012, The Journal of clinical endocrinology and metabolism.

[96]  Yiannis S. Chatzizisis,et al.  Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy Implications for Risk Assessment , Prevention and Treatment , 2012 .

[97]  J. Mes,et al.  β-Glucans are involved in immune-modulation of THP-1 macrophages. , 2012, Molecular nutrition & food research.

[98]  J. Harland.  Food combinations for cholesterol lowering , 2012, Nutrition Research Reviews.

[99]  K. Bose,et al.  Adipocytokine Levels in Genetically High Risk for Type 2 Diabetes in the Indian Population: A Cross-Sectional Study , 2012, Experimental diabetes research.

[100]  M. Orth,et al.  Cholesterol: Its Regulation and Role in Central Nervous System Disorders , 2012, Cholesterol.

[101]  S. Engelsen,et al.  Extracted oat and barley β-glucans do not affect cholesterol metabolism in young healthy adults. , 2013, The Journal of nutrition.

[102]  J. Arthur,et al.  Dectin-1 Regulates IL-10 Production via a MSK1/2 and CREB Dependent Pathway and Promotes the Induction of Regulatory Macrophage Markers , 2013, PloS one.

[103]  J. Anderson,et al.  Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial , 2012, European Journal of Clinical Nutrition.

[104]  V. Vetvicka,et al.  Placebo-driven clinical trials of yeast-derived β-(1-3) glucan in children with chronic respiratory problems. , 2013, Annals of translational medicine.

[105]  P. Šíma,et al.  Immunostimulatory properties and antitumor activities of glucans , 2013, International journal of oncology.

[106]  S. Ahrné,et al.  High-Fat Diet Reduces the Formation of Butyrate, but Increases Succinate, Inflammation, Liver Fat and Cholesterol in Rats, while Dietary Fibre Counteracts These Effects , 2013, PloS one.

[107]  P. Cheung.  Mini-review on edible mushrooms as source of dietary fiber: Preparation and health benefits , 2013 .

[108]  Robert Dufour,et al.  2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. , 2013, The Canadian journal of cardiology.

[109]  Barbara M. Bakker,et al.  The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.

[110]  V. Vetvicka,et al.  Anti-Stress Action of an Orally-Given Combination of Resveratrol, β-Glucan, and Vitamin C , 2014, Molecules.

[111]  F. Kuipers,et al.  Beyond intestinal soap—bile acids in metabolic control , 2014, Nature Reviews Endocrinology.

[112]  R. Josef,et al.  Effects of Transfer Point Glucan #300 Supplementation on Children exposed to Passive Smoking - Placebo-driven Double-blind Clinical Trials , 2014 .

[113]  C. White,et al.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review , 2014, Journal of Lipid Research.

[114]  P. Wilde,et al.  Effect of substituent pattern and molecular weight of cellulose ethers on interactions with different bile salts. , 2015, Food & function.

[115]  F. Fåk,et al.  Effects of two whole-grain barley varieties on caecal SCFA, gut microbiota and plasma inflammatory markers in rats consuming low- and high-fat diets. , 2015, The British journal of nutrition.

[116]  P. A. Williams,et al.  Soluble Fermentable Dietary Fibre (Pectin) Decreases Caloric Intake, Adiposity and Lipidaemia in High-Fat Diet-Induced Obese Rats , 2015, PloS one.

[117]  A. Fodor,et al.  Intrinsic association between diet and the gut microbiome: current evidence. , 2015, Nutrition and dietary supplements.

[118]  R. Martín-Hernández,et al.  Modulation of Cholesterol-Related Gene Expression by Dietary Fiber Fractions from Edible Mushrooms. , 2015, Journal of agricultural and food chemistry.

[119]  X. Zhu,et al.  Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[120]  Sumei Zhou,et al.  Effects of dietary hull-less barley β-glucan on the cholesterol metabolism of hypercholesterolemic hamsters. , 2015, Food chemistry.

[121]  P. Šíma,et al.  Glucans and Cancer: Historical Perspective , 2015 .

[122]  S. Ku,et al.  Effect of polycan, a β-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model , 2015, Experimental and therapeutic medicine.

[123]  V. Vetvicka,et al.  Molecular Interactions of β-(1→3)-Glucans with Their Receptors , 2015, Molecules.

[124]  V. Vetvicka,et al.  β-Glucan attenuates chronic fatigue syndrome in murine model , 2015 .

[125]  N. Maeda,et al.  Oral administration of the Aureobasidium pullulans-derived β-glucan effectively prevents the development of high fat diet-induced fatty liver in mice , 2015, Scientific Reports.

[126]  L. Videla,et al.  Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease , 2015, International journal of molecular sciences.

[127]  J. Chiang,et al.  Bile acids as metabolic regulators , 2015, Current opinion in gastroenterology.

[128]  S. O'keefe.  Diet, microorganisms and their metabolites, and colon cancer , 2016, Nature Reviews Gastroenterology &Hepatology.

[129]  F. Nan,et al.  Ganoderma lucidum beta 1,3/1,6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet , 2016, BMC Complementary and Alternative Medicine.

[130]  Takuya Suzuki,et al.  Dietary Fermentable Fiber Reduces Intestinal Barrier Defects and Inflammation in Colitic Mice. , 2016, The Journal of nutrition.

[131]  V. Vuksan,et al.  The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials , 2016, British Journal of Nutrition.

[132]  P. Jones,et al.  High-Molecular-Weight β-Glucan Decreases Serum Cholesterol Differentially Based on the CYP7A1 rs3808607 Polymorphism in Mildly Hypercholesterolemic Adults. , 2015, The Journal of nutrition.

[133]  P. Souverein,et al.  High risk of drug‐induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors , 2016, Alimentary pharmacology & therapeutics.

[134]  D. Martínez-Carrera,et al.  Hypocholesterolemic Properties and Prebiotic Effects of Mexican Ganoderma lucidum in C57BL/6 Mice , 2016, PloS one.

[135]  P. Barter,et al.  Dysfunctional HDL and atherosclerotic cardiovascular disease , 2016, Nature Reviews Cardiology.

[136]  A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reductioni-iv , 2016, European Journal of Clinical Nutrition.

[137]  Kusmiati,et al.  Cholesterol-Lowering Effect of Beta Glucan Extracted from Saccharomyces cerevisiae in Rats , 2016, Scientia pharmaceutica.

[138]  V. Vetvicka,et al.  Comparison of Immunological Effects of Commercially Available β-Glucans: Part III , 2016 .

[139]  L. Gesualdo,et al.  Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals , 2017, PloS one.

[140]  R. Tungtrongchitr,et al.  Yeast β–Glucan Modulates Inflammation and Waist Circumference in Overweight and Obese Subjects , 2017, Journal of dietary supplements.

[141]  A. Franke,et al.  Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis , 2017, Nature Medicine.

[142]  Hypocholesterolemic Effects of Beta-Glucans In Different Barley Diets Fed To Broiler Chicks ' , 2017 .

[143]  J. Krieger,et al.  Non-HDL cholesterol is a good predictor of the risk of increased arterial stiffness in postmenopausal women in an urban Brazilian population , 2017, Clinics.

[144]  B. Burton-Freeman,et al.  Ratios of soluble and insoluble dietary fibers on satiety and energy intake in overweight pre- and postmenopausal women1 , 2017, Nutrition and healthy aging.

[145]  H. Daida,et al.  Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome. , 2017, International heart journal.

[146]  F. Bäckhed,et al.  Role of gut microbiota in atherosclerosis , 2017, Nature Reviews Cardiology.

[147]  Xiangyi Zheng,et al.  Dietary fiber intake is inversely associated with risk of pancreatic cancer: a meta-analysis. , 2015, Asia Pacific journal of clinical nutrition.

[148]  H. Smidt,et al.  Different Types of Dietary Fibers Trigger Specific Alterations in Composition and Predicted Functions of Colonic Bacterial Communities in BALB/c Mice , 2017, Front. Microbiol..

[149]  G. Hansson,et al.  The immunology of atherosclerosis , 2017, Nature Reviews Nephrology.

[150]  A. Sahebkar,et al.  Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management. , 2017, Pharmacological research.

[151]  F. O'Gara,et al.  Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism , 2017, Microbiome.

[152]  A. Barbieri,et al.  Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment , 2017, Nutrients.

[153]  E. Conte,et al.  Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study , 2017, Front. Pharmacol..

[154]  N. Anh,et al.  Radiation Degradation of β-Glucan with a Potential for Reduction of Lipids and Glucose in the Blood of Mice , 2019, Polymers.